RNXT:NASDAQ, RenovoRx, Inc.

RNXT stock overview

RenovoRx, Inc. (RNXT:NASDAQ) closed at $1.39 on October 27, 2026, up 6.11% on the day. The stock trades 46.3% below its 52-week high of $2.59 and 98.3% above its 52-week low of $0.701. Over the past year, it gained 13.9%. RenovoRx, Inc. is part of the Health Care sector.

Key figures

Price
$1.39
Day change
+6.11%
Volume
289,369
Average volume
804,809
Market cap
62M+
52-week range
$0.701 – $2.59
50-day average
$1.55
200-day average
$1.10

Price action over the past year

In 252 trading sessions since October 27, 2025, RNXT closed higher on 117 days (46%). Its best day was September 2, 2026 (+19.43%) and its worst was November 14, 2025 (-23.00%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

RNXT news

About RenovoRx, Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.

Similar stocks

Find more stocks like RNXT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.